HILL STEPHEN J. (Chief Technical Ops. Officer) sold 0.6% of their position (95.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $1.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/12/2025ACC: 0001866154-25-000006
Officer· Chief Technical Ops. Officer
Since Jun 2021
-95.00
Net shares
Net seller
$1.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
95.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−95.00
Price / share
$16.12
Trade value
$1.53K
% of position
0.6%
11/10/2025
15.85K→15.75K
Total
Net shares
−95.00
Net value
-$1.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/10/2025 | S · Sale | −95.00 | $16.12 | $1.53K | 0.6% | 15.85K | 15.75K |
| Total | −95.00 | -$1.53K | ||||||
Derivative Transactions0
No derivative transactions reported